PF-07921186 / Pfizer - LARVOL DELTA

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (clinicaltrials.gov) - P2 | N=900 | Recruiting | Sponsor: Pfizer | Active, not recruiting ➔ Recruiting

Enrollment open • Herpes Zoster • Infectious Disease • Varicella Zoster

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (clinicaltrials.gov) - P2 | N=900 | Active, not recruiting | Sponsor: Pfizer | Trial completion date: May 2030 ➔ Aug 2030 | Trial primary completion date: Nov 2025 ➔ Feb 2026

Trial completion date • Trial primary completion date • Herpes Zoster • Infectious Disease • Varicella Zoster

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (clinicaltrials.gov) - P2 | N=900 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting

Enrollment closed • Herpes Zoster • Infectious Disease • Varicella Zoster

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (clinicaltrials.gov) - P2 | N=900 | Recruiting | Sponsor: Pfizer | Phase classification: P1/2 ➔ P2

Phase classification • Herpes Zoster • Infectious Disease • Varicella Zoster

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (clinicaltrials.gov) - P1/2 | N=900 | Recruiting | Sponsor: Pfizer | Phase classification: P2 ➔ P1/2

Phase classification • Herpes Zoster • Infectious Disease • Varicella Zoster

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (clinicaltrials.gov) - P2 | N=900 | Recruiting | Sponsor: Pfizer | Trial completion date: Jan 2030 ➔ Aug 2030 | Trial primary completion date: Jul 2025 ➔ Feb 2026

Trial completion date • Trial primary completion date • Herpes Zoster • Infectious Disease • Varicella Zoster

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (clinicaltrials.gov) - P2 | N=900 | Recruiting | Sponsor: Pfizer | Trial primary completion date: Mar 2028 ➔ Jul 2025

Trial primary completion date • Herpes Zoster • Infectious Disease • Varicella Zoster

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (clinicaltrials.gov) - P2 | N=900 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting

Enrollment open • Herpes Zoster • Infectious Disease • Varicella Zoster

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (clinicaltrials.gov) - P2 | N=900 | Not yet recruiting | Sponsor: Pfizer

New P2 trial • Herpes Zoster • Infectious Disease • Varicella Zoster